Identification of receptor interacting protein kinase 3 (RIPK3) type II inhibitors using high-throughput mechanistic studies in hit triage

被引:0
|
作者
Hart, Amy [1 ]
Abell, Lynn [1 ]
Weigelt, Carolyn [1 ]
Guo, Junqing [1 ]
Mertzman, Michael [1 ]
Chaudhry, Charu [1 ]
Lu, Hao [1 ]
Padmanabha, Ramesh [1 ]
Pokross, Matthew [1 ]
Kish, Kevin [1 ]
Douglas, Andrew [1 ]
Columbar, Deepa [1 ]
Zhang, Ping [1 ]
Carpenter, Brian [1 ]
Macor, John [1 ]
Pitts, William [1 ]
机构
[1] Bristol Myers Squibb, Princeton, NJ USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 256卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
56
引用
收藏
页数:1
相关论文
共 34 条
  • [21] Receptor-Interacting Protein Kinase 3 (RIPK3) mRNA Levels Are Elevated in Blood Mononuclear Cells of Patients with Poor Prognosis of Acute-on-Chronic Hepatitis B Liver Failure
    Han, Liyan
    Teng, Yue
    Fan, Yuchen
    Gao, Shuai
    Li, Feng
    Wang, Kai
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 247 (04) : 237 - 245
  • [22] Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform
    Kabir, Md
    Padilha, Elias C.
    Shah, Pranav
    Huang, Ruili
    Sakamuru, Srilatha
    Gonzalez, Eric
    Ye, Lin
    Hu, Xin
    Henderson, Mark J.
    Xia, Menghang
    Xu, Xin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] High-Throughput Screening for Extracellular Inhibitors of the FLT3 Receptor Tyrosine Kinase Reveals Chemically Diverse and Druggable Negative Allosteric Modulators
    Hany, Romain
    Leyris, Jean-Philippe
    Bret, Guillaume
    Mallie, Sylvie
    Sar, Chamroeun
    Thouaye, Maxime
    Hamze, Abdallah
    Provot, Olivier
    Sokoloff, Pierre
    Valmier, Jean
    Villa, Pascal
    Rognan, Didier
    ACS CHEMICAL BIOLOGY, 2022, 17 (03) : 709 - 722
  • [24] Nanoencapsulation of Cordycepin Induces Switching from Necroptosis to Apoptosis in Human Oral Cancer Cells (HSC-4) Through Inhibition of Receptor-Interacting Serine/Threonine-Protein Kinase 3 (RIPK3) and Autophagy Modulation
    Kaokaen, Palakorn
    Chaicharoenaudomrung, Nipha
    Kunhorm, Phongsakorn
    Mesil, Kedkanya
    Binlateh, Thunwa
    Noisa, Parinya
    Jitprasertwong, Paiboon
    NATURAL PRODUCT COMMUNICATIONS, 2022, 17 (01)
  • [25] High-throughput Identification of FLT3 Wild-type and Mutant Kinase Substrate Preferences and Application to Design of Sensitive In Vitro Kinase Assay Substrates
    Perez, Minervo
    Blankenhorn, John
    Murray, Kevin J.
    Parker, Laurie L.
    MOLECULAR & CELLULAR PROTEOMICS, 2019, 18 (03) : 477 - 489
  • [26] Identification of glycogen synthase kinase 3alpha/beta as a host factor required for HBV transcription using high-throughput screening
    Nishitsuji, Hironori
    Naito, Yui
    Murakami, Yuuna
    Sugiyama, Masaya
    Mizokami, Masashi
    Shoji, Ikuo
    Murata, Takayuki
    Shimotohno, Kunitada
    HEPATOLOGY, 2025,
  • [27] Pyrrolo[3,2-d]pyrimidine Derivatives as Type II Kinase Insert Domain Receptor (KDR) Inhibitors: CoMFA and CoMSIA Studies
    Wu, Xiao-Yun
    Chen, Wen-Hua
    Wu, Shu-Guang
    Tian, Yuan-Xin
    Zhang, Jia-Jie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (02) : 2387 - 2404
  • [28] Knockdown of Receptor Interacting Protein kinase-1 (RIPK1) markedly exacerbates immune-mediated liver injury and induces lethality through massive TNFα/caspase-dependent apoptosis of hepatocytes, independently of RIPK3/MLKL-mediated necroptosis.
    Suda, Jo
    Dara, Lily
    Yang, Luoluo
    Gaarde, William A.
    Kaplowitz, Neil
    Liu, Zhang-Xu
    HEPATOLOGY, 2015, 62 : 1247A - 1247A
  • [29] Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold
    Suebsuwong, Chalada
    Dai, Bing
    Pinkas, Daniel M.
    Duddupudi, Anantha Lakshmi
    Li, Li
    Bufton, Joshua C.
    Schlicher, Lisa
    Gyrd-Hansen, Mads
    Hu, Ming
    Bullock, Alex N.
    Degterev, Alexei
    Cuny, Gregory D.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
  • [30] N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetarnido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure-Activity Relationships, and in Vivo Efficacy
    Zhang, Hao
    Xu, Lijuan
    Qin, Xia
    Chen, Xiaofei
    Cong, Hui
    Hu, Longmiao
    Chen, Long
    Miao, Zhenyuan
    Zhang, Wannian
    Cai, Zhenyu
    Zhuang, Chunlin
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (14) : 6665 - 6681